ENGINEERING HIGH-AFFINITY HUMANIZED ANTI-P185(HER2)/ANTI-CD3 BISPECIFIC F(AB')(2) FOR EFFICIENT LYSIS OF P185(HER2) OVEREXPRESSING TUMOR-CELLS Article

ZHU, ZP, LEWIS, GD, CARTER, P. (1995). ENGINEERING HIGH-AFFINITY HUMANIZED ANTI-P185(HER2)/ANTI-CD3 BISPECIFIC F(AB')(2) FOR EFFICIENT LYSIS OF P185(HER2) OVEREXPRESSING TUMOR-CELLS . INTERNATIONAL JOURNAL OF CANCER, 62(3), 319-324. 10.1002/ijc.2910620315

cited authors

  • ZHU, ZP; LEWIS, GD; CARTER, P

sustainable development goals

authors

publication date

  • July 28, 1995

published in

keywords

  • CANCER
  • EXPRESSION
  • HUMAN-BREAST
  • IMMUNOTHERAPY
  • LYMPHOCYTES
  • Life Sciences & Biomedicine
  • MONOCLONAL-ANTIBODIES
  • ONCOGENE
  • Oncology
  • PROTOONCOGENE
  • Science & Technology
  • T-CELLS
  • THERAPY

Digital Object Identifier (DOI)

publisher

  • WILEY

start page

  • 319

end page

  • 324

volume

  • 62

issue

  • 3